← Back to Clinical Trials
Recruiting NCT06623500

NCT06623500 Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06623500
Status Recruiting
Phase
Sponsor Shandong Provincial Hospital
Condition Thyroid Cancer
Study Type OBSERVATIONAL
Enrollment 1,600 participants
Start Date 2012-01-01
Primary Completion 2026-12-01

Trial Parameters

Condition Thyroid Cancer
Sponsor Shandong Provincial Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,600
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2012-01-01
Completion 2026-12-01
Interventions
Iodine excessIodine suitable

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The effect of iodine nutritional status on thyroid cancer has been controversial for many years. We designed a prospective cohort study that recruiting patients in different iodine areas who underwent thyroid cancer surgery in branch hospitals from 2012 to 2019,and follow up their clinical outcomes. We aimed to analyse the relationship between regional iodine nutrition level and pathological types, clinical features, and prognosis of thyroid cancer.

Eligibility Criteria

Inclusion Criteria: 1. Age range: 18\~65 years old, gender not limited; 2. Living in the selected region for at least 5 years; 3. Patients who underwent thyroid surgery at various research centers were pathologically diagnosed with thyroid cancer; 4. The clinical data (general information、surgical scope 、pathological report、utrasonic report, etc )of the case is complete. Exclusion Criteria: 1. Diagnosed as other types of cancer or thyroid metastatic cancer; 2. There are serious comorbidities such as heart, liver, and kidney diseases present; 3. Unable to follow up on prognostic information.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology